US EditionAstraZeneca sets out $15 billion China investment during Starmer visit
AstraZeneca plans to grow its workforce beyond 20,000 and focus on advanced treatments like cell therapy, strengthening China-UK healthcare collaboration and innovation.
- On Thursday, AstraZeneca announced a $15 billion investment in China during Keir Starmer, UK Prime Minister's, visit, with Pascal Soriot, Chief Executive Officer, AstraZeneca, joining the delegation.
- AstraZeneca has operated in China for more than thirty years and maintains two global R&D centres in Beijing and Shanghai; last year it set out plans for a $2.5 billion Beijing R&D centre, the company said.
- Building on recent deals and an acquisition earlier this year, AstraZeneca said it targets cell therapies and radioconjugates across drug discovery, partnering with AbelZeta, CSPC, Harbour BioMed, Jacobio and Syneron Bio.
- The investment will grow AstraZeneca's China workforce beyond 20,000, creating thousands of additional healthcare jobs and expanding manufacturing at Wuxi, Taizhou, Qingdao, and Beijing, which supply 70 markets.
- Amid UK‑China diplomacy, AstraZeneca said the $15 billion investment aligns with Healthy China 2030 and the Common Health agenda, while the White House delayed tariffs for three years.
46 Articles
46 Articles
AstraZeneca deepens China investment
AstraZeneca will invest $15 billion in China through 2030, the British pharmaceutical giant announced Thursday during the UK prime minister’s visit to Beijing. Astra is the biggest foreign drugmaker in China, and has been ramping up its investments there despite scrutiny from authorities: Beijing detained Astra’s top local executive in 2024. The move reflects the recent boom in China’s biotech ecosystem, marked by thousands of new startups, inno…
Pharmalittle: We're reading about AstraZeneca investing in China, an abandoned overdose antidote, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a good start here on the Pharmalot campus, where we have clear blue skies, although the temperature is a bit frigid. Of course, this means that it is time to reheat the coffee kettle for another cup of stimulation. Our choice today is Jack Daniels, a pantry favorite. Please feel free to join us. And now, here are your tidbits. Hope you have a productive and meanin…
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
